MedTrace Logo

Systemic Inflammation in Liver Cirrhosis

NCT04850534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-12-06

No results posted yet for this study

Summary

Investigate systemic inflammation in liver cirrhosis patients

Conditions

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Third Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • Bin Wu, Ph.D · Department of Gastroenterology, Third Affiliated Hospital of Sun Yar-sen University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2022-12-31
Completion
2023-10-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04850534 on ClinicalTrials.gov